- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 339/04 - Five-membered rings having the hetero atoms in positions 1 and 2, e.g. lipoic acid
Patent holdings for IPC class C07D 339/04
Total number of patents in this class: 152
10-year publication summary
10
|
13
|
7
|
10
|
13
|
18
|
10
|
6
|
11
|
5
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Cellix Bio Private Limited | 52 |
9 |
Exerkine Corporation | 33 |
6 |
Research Foundation of the City University of New York | 420 |
6 |
Cellixbio Private Limited | 155 |
5 |
The Government of the United States of America, as represented by the Secretary of the Navy | 1301 |
5 |
Krisani Biosciences (P) Ltd | 8 |
5 |
Novartis AG | 10850 |
4 |
Ischemix LLC | 16 |
4 |
Indigene Pharmaceuticals, Inc. | 9 |
3 |
Jiangsu Tasly Diyi Pharmaceutical Co., Ltd. | 58 |
3 |
Nou-life Sciences, Inc. | 3 |
3 |
Prous Institute for Biomedical Research, S.A. | 9 |
3 |
Santen Pharmaceutical Co., Ltd. | 596 |
3 |
Mitorx Therapeutics Limited | 5 |
3 |
The United States of America as represented by the Secretary of the Navy | 2750 |
2 |
The General Hospital Corporation | 4731 |
2 |
Alnylam Pharmaceuticals, Inc. | 1149 |
2 |
Antibe Therapeutics Inc. | 20 |
2 |
Cedars-Sinai Medical Center | 1154 |
2 |
Cyprus University of Technology | 16 |
2 |
Other owners | 78 |